Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of CVO plus for treatment of COVID-19
PACTR202103601407640Phase 3Completed
- Sponsor
- Pharmalagasy
- Start
- Jan 2021
- Countries
- 1
01
Overview
Phase 3 trial in coronavirus disease 2019 (COVID-19), sponsored by Pharmalagasy. Primary endpoint: Viral load clearance or reduction by day 28. Started Jan 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202103601407640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202103601407640.